GDF-15 and suPAR biomarkers provide incremental prognostic value for short-term risk stratification after transcatheter tricuspid valve intervention.
Do GDF-15 and suPAR provide incremental prognostic value for short-term risk stratification after transcatheter tricuspid valve intervention?
Patients undergoing transcatheter tricuspid valve intervention
GDF-15 and suPAR biomarkers
Short-term risk stratification
GDF-15 and suPAR offer incremental prognostic value for short-term risk stratification following transcatheter tricuspid valve intervention.
Absolute Event Rate: 0% vs 0%
GDF-15 and suPAR provide incremental prognostic value for short-term risk stratification after transcatheter tricuspid valve intervention.
Building similarity graph...
Analyzing shared references across papers
Loading...
Edlinger et al. (Mon,) reported a other. GDF-15 and suPAR biomarkers provide incremental prognostic value for short-term risk stratification after transcatheter tricuspid valve intervention.
synapsesocial.com/papers/6996a887ecb39a600b3ef5fc — DOI: https://doi.org/10.1080/17520363.2026.2628970
Christoph Edlinger
University of Salzburg
Johannes Schlegl
Medizinische Hochschule Brandenburg Theodor Fontane
Marwin Bannehr
Structural Heart Disease
Biomarkers in Medicine
Otto-von-Guericke University Magdeburg
University of Salzburg
Paracelsus Medical University
Building similarity graph...
Analyzing shared references across papers
Loading...